您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > AG-1478 hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AG-1478 hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AG-1478 hydrochloride图片
CAS NO:170449-18-0
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
Tyrphostin AG-1478 hydrochloride
NSC 693255 hydrochloride
产品介绍
AG-1478 hydrochloride (Tyrphostin AG-1478 hydrochloride) 是一种选择性的EGFR酪氨酸激酶抑制剂,IC50为 3 nM。AG-1478 hydrochloride 对HCV和脑心肌炎病毒 (EMCV) 具有抗病毒作用。
生物活性

AG-1478 hydrochloride (Tyrphostin AG-1478 hydrochloride) is a selectiveEGFRtyrosine kinase inhibitor withIC50of 3 nM. AG-1478 hydrochloride has antiviral effects againstHCVandencephalomyocarditis virus (EMCV)[1][2][3][4].

IC50& Target

EGFR

3 nM (IC50)

HCV

 

EMCV

 

体外研究
(In Vitro)

AG-1478 (AG1478) is irreversible for growth regulation of human lung (A549) and prostate (DU145) cancer cell lines, cultured in chemically defined DMEM/F12 medium. AG-1478 seems to be more effective at lower concentrations, but is unable to completely inhibit growth of A549 cells[1]. Inhibition of EGFR by specific tyrosine kinase inhibitor AG-1478 (AG1478) significantly decreases the angiotensin II-mediated synthesis of TGF-β and fibronectin by cardiac fibroblasts. EGFR is pharmacologically inhibited by small-molecule inhibitor AG-1478 with IC50of 4 nM[2]. Both Polyfect (PF) and Superfect (SF) treatment lead to increased apoptosis in HEK 293 cells to a similar extent as assessed by flow cytometry. The antioxidant, tempol, significantly reduced dendrimer-mediated apoptosis for both PF and SF. AG-1478 (AG1478), at a 10-fold higher dose (100 μM) than used in signaling studies, is used as a positive control and significantly induced apoptosis in HEK 293 cells[3].

体内研究
(In Vivo)

Administration of AG-1478 (AG1478) significantly reduces myocardial inflammation, fibrosis, apoptosis, and dysfunction in both two obese mouse models. ApoE-/-mice are first fed with HFD for 8 weeks (ApoE-HFD), and then administrated with AG-1478 (10 mg/kg/day) or 542 (10 mg/kg/day) for another 8 weeks by oral gavage. AG-1478 or 542 treatment blocks HFD induced cardiac EGFR phosphorylation in vivo, without affecting the plasma level of low density lipoprotein (LDL) and total triglyceride (TG)[2]. Administration of EGF (10 nM) leads to a robust and reproducible elevation in EGFR phosphorylation that can be blocked by AG-1478 (AG1478), a known inhibitor of EGFR phosphorylation. Increasing doses of Polyfect (PF) result in a significant reduction in EGF-induced EGFR phosphorylation (p<0.05) but this is to a lesser extent than observed with AG1478[3].

分子量

352.22

Formula

C16H15Cl2N3O2

CAS 号

170449-18-0

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.